Since their 2007 founding, ArrowMark Partners has focused on delivering superior risk-adjusted returns and establishing lasting client partnerships. An employee-owned asset management company, ArrowMark boasts a pedigreed investment team with specialized expertise in alternative credit and growth equity asset classes. ArrowMark currently manages $18.9 billion in assets for a varied client base that includes institutional investors, financial intermediaries and family offices across alternative, traditional and customized investment strategies. For more information, please visit https://arrowmarkpartners.com/about-us/.
Established in 2005, Broadfin Capital is a leading global healthcare investment manager with over $500 million in assets under management. The team has extensive investment experience in the medical technology, pharmaceuticals and biotechnology sectors where it applies a value-oriented investment strategy based on deep, fundamental research and quantitative analysis. Broadfin Capital’s approach is differentiated by its ability to find value-based investments across all market capitalizations, an investment approach to minimize managing binary event risk, a focus on long-term returns and the ability to actively engage management and the board. Broadfin serves a diverse client base that includes high-net-worth individuals, family offices, foundations and endowments. For more information, please visit http://broadfin.com/.
CVF, LLC is the venture capital arm of Henry Crown & Company, a privately owned investment company.
With close to $4 billion raised since inception, EW Healthcare Partners is one of the largest and oldest private healthcare investment firms and seeks to make growth equity investments in fast growing commercial-stage healthcare companies in the pharmaceutical, medical device, diagnostics, and technology-enabled services sectors in the United States and in Europe. Since its founding in 1985, EW Healthcare Partners has maintained its singular commitment to the healthcare industry and has been a long-term investor in over 150 healthcare companies, ranging across sectors, stages and geographies. The team is comprised of over 20 senior investment professionals with offices in Palo Alto, Houston, New York, and London. For more information, see www.ewhealthcare.com.
Fjord Ventures is a life-science focused technology accelerator that provides operational management expertise and a highly capital-efficient shared infrastructure to portfolio companies. Since its formation in 2005, Fjord Ventures has created over 10 companies and, together with its affiliates, invests in its portfolio companies from seed through later-stage rounds. Fjord Ventures and its affiliates hold the largest shareholding block in Sonendo. Sonendo was founded by Olav Bergheim, the founder of Fjord Ventures. For more information, please visit www.fjordventures.com.
General Atlantic is a leading global growth equity firm providing capital and strategic support for growth companies. Established in 1980, General Atlantic combines a collaborative global approach, sector specific expertise, a long-term investment horizon and a deep understanding of growth drivers to partner with great entrepreneurs and management teams to build exceptional businesses worldwide. General Atlantic has more than 100 investment professionals based in New York, Amsterdam, Beijing, Greenwich, Hong Kong, London, Mexico City, Mumbai, Munich, Palo Alto, São Paulo, and Singapore. www.generalatlantic.com.
Meritech Capital Partners is a leading provider of late-stage venture capital to category-defining private technology companies, and has been one of the top performing venture firms of the past decade. With over $3 billion under management, Meritech primarily leads investments into companies with proven and differentiated technology, rapidly growing revenue and experienced management teams. With one of the most active venture portfolios in Silicon Valley, Meritech has experience in, and provides guidance on, issues facing rapidly growing companies including management incentive plans, IPO market timing and positioning, M&A strategies and negotiations and adviser selection. Meritech investments in industry-leading companies include Acclarent, Cornerstone-OnDemand, Facebook, Fortinet, Fusion-io, Greenplum, Hybris, Imperva, Netezza, NetSuite, Proofpoint, PopCap, Riverbed, Salesforce.com, Sourcefire, Tableau and Zulily. Meritech is located in Palo Alto, CA. For more information, please visit www.meritechcapital.com.
NeoMed Management is an international investment firm, exclusively focusing on the healthcare industry. Founded in 1996, NeoMed has established five funds, with total committed capital exceeding $250 million. NeoMed invests very selectively in emerging medical products companies with outstanding growth prospects. For more information, please visit www.neomed.net.
OrbiMed is a leading investment firm dedicated exclusively to the healthcare sector, with approximately $11 billion in assets under management. OrbiMed invests globally across the spectrum of healthcare companies, from venture capital start-ups to large multinational companies. OrbiMed’s team of more than 80 employees manages a series of private equity funds, public equity funds, royalty/debt funds and other investment vehicles. OrbiMed maintains its headquarters in New York City, with additional offices in San Francisco, Shanghai, Mumbai and Herzliya. For more information, please visit www.orbimed.com.
Perceptive Advisors was founded in 1999 with a focus on investing in promising technologies in healthcare, including innovations in biotechnology, diagnostics, pharmaceuticals, digital health and medical devices. For more information, please visit https://www.perceptivelife.com/about-us/.
SEB Private Equity is a part of Skandinaviska Enskilda Banken (SEB) and invests capital from top-tier third party institutions. Established in 1856, SEB is one of the major Nordic banks with strong historic linkage to the industrial sector. Since its formation in 1998, SEB Private Equity has become a leading global private equity investor based in the Nordics focusing on developing companies both operationally and strategically by partnering with entrepreneurs and managers.
SEB Private Equity has managed to build a highly networked and experienced team with the skill-set to source proprietary investment opportunities from its networks, execute on transactions, strategically and operationally improve the company fundamentals and as such create value for investors over the long-term. Combined over the various investment strategies, SEB Private Equity manages about USD 4bn in capital on behalf of clients. For more information, please visit sebgroup.com.